This site is intended for healthcare professionals

Targeted therapies in HER2 positive breast cancer

Read time: 6 mins
Last updated:23rd Aug 2019
Published:1st Aug 2019
Source: Medthority
This is the second of a four-part series looking at the latest trends in treatments developed for breast cancer. Here we highlight the current and latest therapies for the HER2 positive subtype of breast cancer, including trastuzumab and next generation treatments such as margetuximab.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.